Abstract:The in-situ synthesis of degradable polymer prodrug nanoparticles is still a challenge to be met, which would make it possible to remedy both the shortcomings of traditional formulation of preformed polymers (e.g., low nanoparticle concentrations) and those of the physical encapsulation of drugs (e.g., burst release, poor drug loadings). Herein, by the combination of radical ring-opening polymerization (rROP) and polymerization-induced self-assembly (PISA) under appropriate experimental conditions, we report the successful preparation of high solid contents, degradable polymer prodrug nanoparticles, exhibiting multiple drug moieties covalently linked to a degradable vinyl copolymer backbone. Such rROPISA process relied on a chain extension of a biocompatible poly(ethylene glycol)-based solvophilic block with a mixture of lauryl methacrylate (LMA), cyclic ketene acetal (CKA) and drug-bearing methacrylic esters by reversible addition fragmentation chain transfer (RAFT) copolymerization at 20 wt % solids content. This novel approach was exemplified with two different CKA monomers and two different anticancer drugs, namely paclitaxel and gemcitabine, to demonstrate its versatility. After transferring to water, remarkably stable aqueous suspensions of core-degradable polymer prodrug nanoparticles of 56-225 nm in diameter with tunable amounts of CKA units (7-26 mol.%) and drug loadings up to 33 wt % were obtained. Incorporation of ester groups in the copolymers was demonstrated by hydrolytic degradation of both the copolymers and the nanoparticles under accelerated conditions. The nanoparticles showed significant cytotoxicity on A549 cells, used as a lung cancer model. Fluorescence labeling of the solvophilic block also enabled effective monitoring of their cell internalization by confocal microscopy, with the potential for theranostic applications.

Novel L-Amino Acid Ester Prodrugs of Azacitidine: Design, Enzymatic Synthesis and the Investigation of Release Behavior

Degradability of the Linear Azo Polymer Conjugated 5,5′‐azodisalicylic Acid Segment in the Main Chain for Colon‐specific Drug Delivery

An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety

Chemoenzymatic Synthesis, Characterization, and Controlled Release of Functional Polymeric Prodrugs with Acyclovir As Pendant

New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment

Synthesis and release studies on amylose-based ester prodrugs of fenamic acid NSAIDs

In Situ Synthesis of Degradable Polymer Prodrug Nanoparticles

Controllable Synthesis of Polymerizable Ester and Amide Prodrugs of Acyclovir by Enzyme in Organic Solvent

Efficient Synthesis of Polymer Prodrug by Thiol–Acrylate Michael Addition Reaction and Fabrication of Ph-Responsive Prodrug Nanoparticles

Promiscuous Zinc‐Dependent Acylase‐Mediated One‐Pot Synthesis of Monosaccharide‐Containing Pyrimidine Derivatives in Organic Medium

Novel prodrugs with a spontaneous cleavable guanidine moiety

Enhanced Plasma Stability and Potency of Aryl/Acyloxy Prodrugs of a BTN3A1 Ligand

Controllable selective enzymatic synthesis of N-acyl and O-acylpropranolol vinyl esters and preparation of polymeric prodrug of propranolol

Palladium-Catalyzed Regio- and Stereoselective Allylic Alkylation of 5-Vinyloxazolidine-2,4-diones with Azlactones: Synthesis of Chiral (Z)-Trisubstituted Allylic Amino Acid Derivatives

Design and synthesis of 5-azacytidine analogs

The synthesis of amphipathic prodrugs of 1,2-diol drugs with saccharide conjugates by high regioselective enzymatic protocol.

Azaphilones As Activation‐Free Primary‐Amine‐Specific Bioconjugation Reagents for Peptides, Proteins and Lipids

Novel Sustained Release Azithromycin Resinate Fabricated by One-Pot Ion-exchange Performed in Hydro-alcoholic Solution

Synthesis of Monosaccharide Derivatives and Polymeric Prodrugs of 5-Fluorouridine Via Two-Step Enzymatic or Chemo-Enzymatic Highly Regioselective Strategy

Synthesis and Characterization of Optically Active Macromolecular Prodrugs with Chemo-Enzymatic Protocol

A new synthesis of the amine fragment: an important intermediate to the anti-HIV drug lenacapavir